Rhythm Pharmaceuticals (RYTM) EBITDA (2016 - 2026)
Rhythm Pharmaceuticals' EBITDA was -$43.93 million in Q3 2021, compared with -$34.11 million a year earlier.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) EBITDA (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Rhythm Pharmaceuticals' EBITDA was -$153.13 million through Sep 30, 2021; for FY2020, it was -$135.89 million.
- In earlier years, EBITDA was -$145.17 million in FY2019, -$77.98 million in FY2018, -$32.19 million in FY2017 and -$25.76 million in FY2016.
- The Q3 2021 figure marks the lowest quarterly EBITDA since Q2 2019.
- Per Business Quant data, RYTM's EBITDA in the three quarters before Q3 2021 was -$40.12 million (Q2 2021), -$34.2 million (Q1 2021) and -$34.9 million (Q4 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Rhythm Pharmaceuticals | 7.90 Bn | 6.52 Bn | 79.96 Mn | -39.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -39.02 Mn |
| Jun 30, 2026 | -48.30 Mn |
| Mar 31, 2026 | -52.11 Mn |
| Dec 31, 2025 | -46.79 Mn |
| Sep 30, 2025 | -52.35 Mn |
| Jun 30, 2025 | -44.92 Mn |
| Mar 31, 2025 | -46.62 Mn |
| Dec 31, 2024 | -40.87 Mn |
| Sep 30, 2024 | -43.50 Mn |
| Jun 30, 2024 | -40.09 Mn |
| Mar 31, 2024 | -135.47 Mn |
| Dec 31, 2023 | -36.83 Mn |
| Sep 30, 2023 | -40.36 Mn |
| Jun 30, 2023 | -43.03 Mn |
| Mar 31, 2023 | -49.01 Mn |
| Dec 31, 2022 | -38.46 Mn |
| Sep 30, 2022 | -36.68 Mn |
| Jun 30, 2022 | -44.66 Mn |
| Mar 31, 2022 | -52.34 Mn |
| Dec 31, 2021 | -50.66 Mn |
API Access
Rhythm Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RYTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();